Howe & Rusling’s Evolus EOLS Stock Holding History

Howe & Rusling’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-40	Closed	–	–	831
2018 Q4	$0	Hold	40	–	–	﹤0.01%	845
2018 Q3	$1K	Hold	40	–	–	﹤0.01%	780
2018 Q2	$1K	Buy	+40	New	+$706	﹤0.01%	738

Other funds holding EOLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

TCM

Tygh Capital Management Portland, Oregon $782M AUM 39.44% 1-Year Est. Return

Wafra Inc New York $5.95M AUM 6.19% 1-Year Est. Return

Howe & Rusling's EOLS Position: Q1 2019 in Review

Howe & Rusling sold out of Evolus (EOLS) in Q1 2019, closing a stake of 40 shares.

Howe & Rusling first reported a position in EOLS in Q2 2018 and held it in 3 quarters. The position peaked at $1K in Q3 2018. 94 funds tracked by Wall St. Rank hold EOLS as of Q1 2019.

Howe & Rusling reported no remaining Evolus position as of Q1 2019 after selling out during the quarter.
Howe & Rusling sold 40 Evolus shares in Q1 2019.
Howe & Rusling first reported a position in Evolus in Q2 2018 and held it in 3 quarters.
Howe & Rusling's Evolus position peaked at $1K in Q3 2018.
94 funds tracked by Wall St. Rank held Evolus as of Q1 2019.

Based on Howe & Rusling's 13F filing for Q1 2019, filed 29 Apr 2019.